Philips announces collaboration with Medtronic to further advance the image-guided treatment of atrial fibrillation
May 09 2019 - 10:29AM
Philips announces collaboration with Medtronic to further advance
the image-guided treatment of atrial fibrillation
May 9, 2019
Philips’ integrated solution will combine the unique KODEX-EPD
dielectric imaging and navigation system, dielectric imaging
sensors, clinical software, and services to support cryoablation
procedures performed with the Medtronic Arctic Front Advance™
cryoablation technology
Amsterdam, The Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA) today announced a collaboration with
Medtronic to further advance treatment of paroxysmal atrial
fibrillation (PAF), a common heart rhythm disorder. Through the
agreement, Medtronic will facilitate sales of products on behalf of
Philips to provide an innovative, integrated image guidance
solution for cryoablation procedures. Philips will bring to market
the novel KODEX-EPD cardiac imaging and navigation system with
cryoablation specific features to enable electrophysiologists to
perform cryoablation procedures with reduced need for X-ray
imaging.
Atrial fibrillation (AF) affects more than 33 million people
worldwide [1]. Cryoballoon ablation is used in a minimally invasive
procedure to isolate the pulmonary veins, which are a source of
erratic electrical signals that cause AF. The technology uses cold
energy rather than heat (radio frequency (RF) ablation) to create
scar tissue and interrupt these irregular electrical pathways in
the heart.
“This integrated solution can guide physicians during the
treatment of AF patients with ablation, as they can view detailed,
CT-like 3D anatomy, reducing the need for X-ray imaging,” said
Marlou Janssen, Business Leader Philips EPD Solutions. “Partnering
with Medtronic extends the reach of our KODEX-EPD cardiac imaging
and navigation system. Today, this technology is simplifying
navigation, and in the future it has potential for a wide range of
applications, including addressing the key unmet need of real-time
therapy assessment – one of the more significant limitations of the
current standard of care.”
"When available, physicians will have the ability to use an
innovative cardiac imaging and mapping system during
cryoablation procedures, while also realizing the significant
benefits of our best-in-class cryoablation therapy," said Rebecca
Seidel, vice president and general manager of the Atrial
Fibrillation Solutions division, which is part of the Cardiac and
Vascular Group at Medtronic. “AF is a growing epidemic and we are
committed to providing solutions to electrophysiologists that help
address the needs of their patients."
Philips’ KODEX-EPD system uses dielectric imaging to create
CT-like 3D, high-definition images of a patient’s cardiac
structures in real time [2]. A completely new approach to imaging
the heart, dielectric imaging offers many benefits in comparison to
current approaches, for both cryo and RF ablation procedures. The
technology provides real-time 3D imaging, reducing the need for
X-ray imaging. It also has mapping capabilities without the need to
reset a reference point if the patient moves. As a result, the
KODEX-EPD system provides excellent visualization and simplifies
navigation, enhancing procedure efficiency and patient care.
In pulmonary vein isolation (PVI) cryoablation procedures, the
system confirms the positioning of the Medtronic Achieve™ Mapping
Catheter, supporting quick visualization of the pulmonary veins.
Philips is also developing balloon visualization capabilities for
the KODEX-EPD system.
KODEX-EPD is CE marked and has received 510(k) clearance from
the U.S. Food and Drug Administration (FDA) for mapping and
navigation during arrhythmia ablation procedures. KODEX-EPD systems
are in clinical use at limited sites worldwide. The integrated
solution to support cryoablation procedures is intended to be
available for sale in the U.S. and Europe in Q4 2019.
[1] Chugh S, Havmoeller R, Narayanan K, et al. Worldwide
epidemiology of atrial fibrillation: a global burden of disease
2010 study. Circulation. 2014; 129:837-847.[2] Maurer T, Kuck K-H
et al. First clinical experience in high-resolution imaging of left
atrial anatomy using a novel wide-band dielectric mapping system.
Clin Res Cardiol 108, Suppl 1, April 2019.
For further information, please contact:
Mark GrovesPhilips Group Press OfficeTel: +31 631 639 916Email:
mark.groves@philips.comTwitter: mark_groves
Fabienne van der FeerPhilips Image Guided TherapyTel: +31 622
698 001Email: fabienne.van.der.feer@philips.comTwitter: FC_Feer
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2018 sales of EUR 18.1 billion and
employs approximately 77,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips_KODEX-EPD_dielectric_imaging_Azurion
- Philips_KODEX-EPD_dielectric_imaging_Azurion_control_room
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024